Dr. Harvey Klein,
AABB’s current president, talked about the success story of blood safety – and what still needs to be addressed.

Brian McDonough,
President of Blood Products, Pall Medical, in North America, introduced the audience to the Pall Purecell® Pathogen Reduction System and laid out the goals and benefits of this exciting new technology.

Dr. Elizabeth Palavecino,
A member of the Department of Pathology at the University Hospitals of Cleveland and Case Western Reserve University, discussed bacteria contamination, its status as a significant cause of mortality and morbidity with regard to transfusions, and the novel approach taken by the new Pall BDS System.

Dr. Stanley Prusiner,
Nobel laureate, Director of the Institute for Neurodegenerative Diseases, and a professor of neurology and biochemistry at UCSF, addressed this prion biology as well as variant CJD, and the therapeutic approaches to these diseases.